Metabolic Syndrome, Independent Predictor for Coronary Artery Disease

被引:20
作者
Zidi, Wiem [1 ,2 ]
Allal-Elasmi, Monia [3 ,4 ]
Zayani, Yosra [3 ,4 ]
Zaroui, Amira [5 ]
Guizani, Imen [3 ,4 ]
Feki, Moncef [3 ,4 ]
Mourali, Mohamed Sami [5 ]
Mechmeche, Rachid [5 ]
Kaabachi, Naziha [3 ,4 ]
机构
[1] Carthage Univ, Rabta Hosp, Res Lab LR99ES11, Tunis, Tunisia
[2] Carthage Univ, Rabta Hosp, Dept Biochem, Tunis, Tunisia
[3] El Manar Univ, Rabta Hosp, Res Lab L99ES11, Tunis, Tunisia
[4] El Manar Univ, Rabta Hosp, Dept Biochem, Tunis, Tunisia
[5] El Manar Univ, Rabta Hosp, Dept Cardiol, Tunis, Tunisia
关键词
metabolic syndrome; coronary artery disease; Gensini score; SYNDROME SCORE; RISK-FACTORS; LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; SEVERITY; ATHEROSCLEROSIS; PREVALENCE; EXTENT; ASSOCIATION;
D O I
10.7754/Clin.Lab.2015.150219
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Metabolic syndrome (MS) was reported to be associated with coronary artery disease (CAD). The aim of the present study was to assess the association between MS and CAD angiographic severity and to search the predictive value of MS and its individual components for CAD. Methods: 428 patients who underwent elective coronary angiography at the Cardiology Department were included in the study. MS was defined according to National Cholesterol Education Program (NCEP) Adult Treatment Panel III criteria. CAD severity was determined by Gensini scors. Results: The proportion of CAD (+) who had MS was significantly higher compared to CAD (-) (63.6% vs. 48.6%, p = 0.020). Gensini score and number of MS components were positively correlated (r = 0.144, p = 0.019). The adjusted predictive abilities for angiographic CAD of MS and its individual components showed that high FBG and high TG are predictive factors for CAD in binary logistic regression analysis (OR = 2.238, 95% CI 1.111 - 4.508, p = 0.024 vs. OR = 2.200, 95% CI 1.078 - 4.492, p = 0.030). The OR for CAD risk of different phenotypes in high FBG and/or HTG shows that this combination increased the OR significantly to 2.307. Among the quartets, the cluster with high BP and low HDL-C was the highest risk (OR = 4.879). However, the combination including all components of MS was a significant contributor to CAD risk. Conclusions: The MS score correlates with the angiographic severity of CAD. The predictive ability for CAD was stronger with high FBG and high TG and associated low HDL-C and high BP, which seem to act synergistically as risk factors for CAD. Therefore, to prevent or decrease this risk of CAD, clinicians should screen for individual abnormalities of MS, mainly elevated blood glucose level and TG.
引用
收藏
页码:1545 / 1552
页数:8
相关论文
共 50 条
  • [31] Relationship between metabolic syndrome and angiographic severity of coronary artery disease
    Miri, Reza
    Sajjadieh, Amir
    Parsamahjoob, Mohammad
    Hajibaratali, Bahareh
    Shekarchizadeh, Masood
    Kolahi, Ali Asghar
    Sadeghi, Mehran
    Ahmadi, Zahra
    Farmanara, Hamedreza
    Shekarchizadeh-Esfahani, Mansoureh
    ARYA ATHEROSCLEROSIS, 2016, 12 (05) : 220 - 225
  • [32] Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline
    Won, Ki-Bum
    Park, Eun Ji
    Han, Donghee
    Lee, Ji Hyun
    Choi, Su-Yeon
    Chun, Eun Ju
    Park, Sung Hak
    Han, Hae-Won
    Sung, Jidong
    Jung, Hae Ok
    Chang, Hyuk-Jae
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [33] Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
    Franco-Pelaez, Juan Antonio
    Martin-Reyes, Roberto
    Pello-Lazaro, Ana Maria
    Acena, Alvaro
    Lorenzo, Oscar
    Martin-Ventura, Jose Luis
    Blanco-Colio, Luis
    Gonzalez-Casaus, Maria Luisa
    Hernandez-Gonzalez, Ignacio
    Carda, Rocio
    Martin-Mariscal, Maria Luisa
    Egido, Jesus
    Tunon, Jose
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 13
  • [34] Does metabolic syndrome predict significant angiographic coronary artery disease?
    Timoteo, Ana Teresa
    Carmo, Miguel Mota
    Ferreira, Rui Cruz
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (12) : 769 - 778
  • [35] Is metabolic syndrome related with coronary artery disease severity and complexity: An observational study about IDF and AHA/NHLBI metabolic syndrome definitions
    Aykan, Ahmet Cagri
    Gul, Ilker
    Kalaycioglu, Ezgi
    Gokdeniz, Tayyar
    Hatem, Engin
    Mentese, Umit
    Yildiz, Banu Sahin
    Yildiz, Mustafa
    CARDIOLOGY JOURNAL, 2014, 21 (03) : 245 - 251
  • [36] Positive correlation of serum angiopoietin-like protein 3 levels with metabolic syndrome in patients with coronary artery disease
    Lian, Sy-Harn
    Hsu, Bang-Gee
    Wang, Ji-Hung
    Chen, Ming-Chun
    TZU CHI MEDICAL JOURNAL, 2022, 34 (01): : 75 - 81
  • [37] Serum γ-Glutamyltransferase: Independent Predictor of Risk of Diabetes, Hypertension, Metabolic Syndrome, and Coronary Disease
    Onat, Altan
    Can, Gunay
    Ornek, Ender
    Cicek, Gokhan
    Ayhan, Erkan
    Dogan, Yuksel
    OBESITY, 2012, 20 (04) : 842 - 848
  • [38] Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome
    Ni, Jie
    Ma, Xiaojing
    Zhou, Mi
    Pan, Xiaoping
    Tang, Junling
    Hao, Yaping
    Lu, Zhigang
    Gao, Meifang
    Bao, Yuqian
    Jia, Weiping
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [39] Impact of Metabolic Syndrome and Its Individual Components on the Presence and Severity of Angiographic Coronary Artery Disease
    Kim, Jong-Youn
    Mun, Hee-Sun
    Lee, Byoung Kwon
    Yoon, Seong Bo
    Choi, Eui-Young
    Min, Pil-Ki
    Yoon, Young-Won
    Hong, Bum-Kee
    Rim, Se-Joong
    Kwon, Hyuck Moon
    YONSEI MEDICAL JOURNAL, 2010, 51 (05) : 676 - 682
  • [40] Metabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease Patients
    Chen, Yen-Chih
    Hsu, Bang-Gee
    Wang, Ji-Hung
    Lee, Chung-Jen
    Tsai, Jen-Pi
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2065 - 2073